Article

Mmarketwatch.com on 2022-01-25 16:39

Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments6 min read

One day after the U.S. Food and Drug Administration said it's halting the use of antibody drugs as COVID-19 treatments because they don't work on the ...

Related news

Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine CNN International
Downing Street
Pfizer, BioNTech begin Omicron vaccine trial timesofisrael.com
China , Greece , Thessaloniki , Israel , United States
US FDA authorizes BioNTech-Pfizer COVID vaccine Deutsche Welle Englisch
United States , Germany
Early Pfizer, BioNTech data suggests boosters may protect against Omicron Sydney Morning Herald
University Hospital , South Africa , United Kingdom , Europe , United States
HPfizer and BioNTech Launch Trial of Omicron-Targeted COVID Vaccine hamodia.com
Israel , New York
Pfizer-BioNTech start trials of new Omicron jab BBC
China , South Africa , United States
Pfizer-BioNTech Says Booster Offers Significant Protection Against Omicron The New York Times
Pfizer, BioNTech say third dose neutralizes omicron variant Star Telegram
Africa , New York
Pfizer, BioNTech start clinical trial for vaccine targeting Omicron variant New York Post
FDA expands Pfizer boosters for more teens as omicron surges abqjournal.com
Israel , New Mexico
Pfizer-BioNTech Begins Clinical Trial of Omicron-Targeted Vaccine observer.com
South Africa , Germany
Pfizer, BioNTech begin study of omicron-specific COVID vaccine The Fresno Bee
Germany
FDA expands Pfizer boosters to younger teens as omicron surges Alaska Dispatch News
Israel , Des Plaines